Crispr Therapeutics shares owned by HC Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by HC Advisors
from 13F filings
Historical chart of HC Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by HC Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by HC Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $270k | 4.3k | 62.60 |
| 2023-06-30 | $225k | 4.0k | 56.14 |
| 2023-03-31 | $212k | 4.7k | 45.23 |
| 2022-12-31 | $216k | 5.3k | 40.65 |
| 2022-09-30 | $3.5M | 54k | 65.35 |
| 2022-06-30 | $452k | 7.4k | 60.82 |
| 2022-03-31 | $457k | 7.3k | 62.79 |
| 2021-12-31 | $643k | 8.5k | 75.75 |
| 2021-09-30 | $644k | 5.8k | 112.00 |
| 2021-06-30 | $924k | 5.7k | 161.91 |
| 2021-03-31 | $564k | 4.6k | 121.81 |
| 2020-12-31 | $646k | 4.2k | 153.15 |
| 2020-09-30 | $320k | 3.8k | 83.55 |
| 2020-06-30 | $269k | 3.7k | 73.56 |